Clinical Trial Update: Venetoclax in Patients With MDS or AML in Relapse After AHSCT [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating venetoclax in patients with myelodysplastic syndromes or acute myeloid leukemia relapsing after allogeneic stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: MDS, AML | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING